Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic. A EUCAST, ESGARS and EPASG Perspective

25.09.2018 - 28.09.2018 All day

• Explain the process of EUCAST breakpoint definition
• Understand the rationale for EUCAST clinical breakpoints including the PK/PD approach and explain implementation of EUCAST breakpoints
• Perform antimicrobial susceptibility testing by dilution, diffusion and automatic techniques with a EUCAST perspective and explain differences from the CLSI approach
• Understand the application of EUCAST expert rules for antimicrobial susceptibility testing and their clinical implications
• Explain antimicrobial surveillance systems (public versus private) and benefits for establishment of antimicrobial guidelines and the design of antibiotic policies
• Understand the importance of epidemiological cut-off values (ECOFFs) and clinical breakpoints in antimicrobial resistance surveillance systems
• Understand how ECOFFs are determined

Sören G. Gatermann